Maggie Berardino, MPH’s Post

Effectiveness of de-implementation of low-value healthcare practices >> "... change infrastructure and workflow and develop stakeholder interrelationships emerged as the most encouraging avenues." https://lnkd.in/ei-W6atr

Partnerships between different stakeholders in the healthcare industry are crucial for driving healthcare transformation. Stakeholders can include diverse groups – not just payors, governments and providers, but also pharma companies, academic centers and private practices. But by working together, these stakeholders can address challenges such as treating complex diseases, reducing costs, and increasing efficiency, all while improving patient outcomes. If you can figure out how to work together, everybody comes at it from a unique angle, each stakeholder uses different tools…collaboration is something that is unique. It doesn’t happen often where you have all these different players all trying to work together, with one common agenda that ultimately benefits the patients.” https://lnkd.in/eKQ-424e

The healthcare industry is increasingly focused on patient-centricity. From personalised medicine to regulatory shifts, there’s a growing recognition that effective solutions come from understanding the patient’s perspective. Our recent blog uncovers more about the growing importance of patient-centricity in market research, the factors driving the rise, the evolving role of market research in capturing patient insights, and the key challenges and opportunities in creating more patient-focused healthcare solutions. 🔗 Read the full blog > https://hubs.ly/Q02QMdps0 #PatientCentricity #Healthcare #MarketResearch #PersonalisedMedicine #PatientEngagement

Transforming healthcare together

Had a great time speaking at Pharma 4.0 Summit in Munich!  Thanks Bernard Gauthier, Sören Fritsche and Gabriel Bohl for the insightful discussion on Pharma’s role to increase crisis resilience of healthcare delivery. 💡 My Key Takeaways are: 1️⃣ Global GP Shortage - Patients and Pharma are both at risk: Disruption of prescription rates and medication adherence negatively affect patients and pose a risk to Pharma core product revenue. 2️⃣ Digital Health could make the Difference: Connecting Pharma products to suitable digital health solutions could be decisive for patient outcomes and commercial success; examples include companion apps to avoid adherence reduction, AI-based clinical decision support and diagnostics to guide prescriptions decisions. 3️⃣ Feasible Strategies yet have to be developed: Pharma has not yet achieved significant strategic impact with digital health (despite case-base successes); companies need to build up competencies to address current uncertainties in user adoption, reimbursement and integration to health systems. 4️⃣ Digital Pharma Communication can bridge potential loss of personal touchpoints in crises; key impact lever is real-time delivery of easy-to-understand and validated content. 5️⃣ Decentralised Clinical Trials increase R&D resilience; significant learning curve during COVID19 pandemic for Pharma and regulators provide momentum to establish DCTs as standard practice. On a scientific note, I personally found the work of Dr. Ingo Gorr and his colleagues from Boehringer Ingelheim on Oncolytic Viruses especially exciting! Thanks Conferenzia World for the invitation, looking forward to the next event.

Highly relevant article from David Traub on a future vision for the Swiss healthcare system. We can indeed learn from countries like Finland, which has introduced an opt-out system for sharing personal health data with research and social systems. For more information on digital transformation of the Swiss healthcare system, I also recommend the Oliver Wyman study: Digital Health: Verpasst die Schweiz die digitale Zukunft? https://lnkd.in/dfX3hy4A

The 2024 Access to Medicine Index, released every 2 years by the Access to Medicine Foundation, highlights progress and persistent gaps in global healthcare, urging action on #clinicaltrials, local access, and equitable medicine distribution. Read at The Evidence Base® #healthdata #healthequity #marketaccess #stakeholderengagement

Modernising Healthcare Data Infrastructure Imagine a future where patients can easily access their medical records and actively participate in clinical trials. Whyze Health's digital platform revolutionises healthcare by empowering patients and enhancing clinical trials through a modernised data infrastructure. Our platform enables patients to access their health records, learn about new treatments, and engage in real-time condition monitoring. This patient-centred approach benefits healthcare providers by extending their reach and revenue through research and clinical trial involvement. Discover how Whyze Health is changing the game in clinical trials and patient-centric care. Read the full article by our CMO, Professor Frank Sullivan, in the  ACRP - Association of Clinical Research Professionals  (Pages 20-21): https://lnkd.in/eJircaPy or online: https://lnkd.in/ehyxrWe8 #HealthcareInnovation #ClinicalTrials #PatientCare #WhyzeHealth

New article! 🔔 Did you know that as clinical trials grow in volume and complexity, their success increasingly hinges on a deep understanding of health system dynamics? How can healthcare leaders leverage the value of health systems to boost clinical trial effectiveness? Read our latest article to find out > https://lnkd.in/eh23VBPj Curious how TKG can help retool your immersion strategy? Contact us through our LinkedIn inbox or visit https://lnkd.in/e3W7mCf6 #clinicaltrials #healthsystems #immersion #strategy